{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:08:59Z","timestamp":1793160539149,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T00:00:00Z","timestamp":1691798400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johns Hopkins University Fisher Center Discovery Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Antiviral drugs are used globally as treatment and prophylaxis for long-term and acute viral infections. Even though antivirals also have been shown to have off-target effects on bacterial growth, the potential contributions of antivirals to antimicrobial resistance remains unknown. Herein we explored the ability of different classes of antiviral drugs to induce antimicrobial resistance. Our results establish the previously unrecognized capacity of antivirals to broadly alter the phenotypic antimicrobial resistance profiles of both gram-negative and gram-positive bacteria\u00a0<jats:italic>Escherichia coli<\/jats:italic>\u00a0and\u00a0<jats:italic>Bacillus cereus<\/jats:italic>.\u00a0Bacteria exposed to antivirals including zidovudine, dolutegravir and raltegravir developed cross-resistance to commonly used antibiotics including trimethoprim, tetracycline, clarithromycin, erythromycin, and amoxicillin. Whole genome sequencing of antiviral-resistant <jats:italic>E. coli<\/jats:italic> isolates revealed numerous unique single base pair mutations, as well as multi-base pair insertions and deletions, in genes with known and suspected roles in antimicrobial resistance including those coding for multidrug efflux pumps, carbohydrate transport, and cellular metabolism. The observed phenotypic changes coupled with genotypic results indicate that bacteria exposed to antiviral drugs with antibacterial properties in vitro can develop multiple resistance mutations that confer cross-resistance to antibiotics. Our findings underscore the potential contribution of wide scale usage of antiviral drugs to the development and spread of antimicrobial resistance in humans and the environment.<\/jats:p>","DOI":"10.1038\/s42003-023-05177-3","type":"journal-article","created":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T08:01:30Z","timestamp":1691827290000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Bacteria exposed to antiviral drugs develop antibiotic cross-resistance and unique resistance profiles"],"prefix":"10.1038","volume":"6","author":[{"given":"Veronica J.","family":"Wallace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric G.","family":"Sakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Preheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1470-141X","authenticated-orcid":false,"given":"Carsten","family":"Prasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,12]]},"reference":[{"key":"5177_CR1","doi-asserted-by":"crossref","first-page":"205873842110026","DOI":"10.1177\/20587384211002621","volume":"35","author":"S Kausar","year":"2021","unstructured":"Kausar, S. et al. A review: Mechanism of action of antiviral drugs. Int. J. Immunopathol. Pharmacol. 35, 20587384211002620 (2021).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"5177_CR2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","volume":"29","author":"E De Clercq","year":"2016","unstructured":"De Clercq, E. & Li, G. Approved antiviral drugs over the past 50 years. Clin. Microbiol. Rev. 29, 695\u2013747 (2016).","journal-title":"Clin. Microbiol. Rev."},{"key":"5177_CR3","unstructured":"UNAIDS. Fact Sheet 2021 Global HIV Statistics. https:\/\/www.unaids.org\/en\/resources\/fact-sheet (2021)."},{"key":"5177_CR4","unstructured":"WHO. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections. https:\/\/www.who.int\/publications\/i\/item\/9789240027077 (2021)."},{"key":"5177_CR5","doi-asserted-by":"crossref","first-page":"e0140765","DOI":"10.1371\/journal.pone.0140765","volume":"10","author":"KJ Looker","year":"2015","unstructured":"Looker, K. J. et al. Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS One 10, e0140765 (2015).","journal-title":"PLoS One"},{"key":"5177_CR6","unstructured":"WHO. Influenza (Seasonal). https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal) (2018)."},{"key":"5177_CR7","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1039\/D0CS01118E","volume":"50","author":"CS Adamson","year":"2021","unstructured":"Adamson, C. S. et al. Antiviral drug discovery: preparing for the next pandemic. Chem. Soc. Rev. 50, 3647\u20133655 (2021).","journal-title":"Chem. Soc. Rev."},{"key":"5177_CR8","doi-asserted-by":"publisher","unstructured":"Fischer, W. et al. Molnupiravir, an oral antiviral treatment for COVID-19. medRxiv. https:\/\/doi.org\/10.1101\/2021.06.17.21258639 (2021).","DOI":"10.1101\/2021.06.17.21258639"},{"key":"5177_CR9","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/AAC.31.2.274","volume":"31","author":"LP Elwell","year":"1987","unstructured":"Elwell, L. P. et al. Antibacterial activity and mechanism of action of 3\u2019-azido-3\u2019-deoxythymidine (BW A509U). Antimicrob. Agents Chemother. 31, 274\u2013280 (1987).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5177_CR10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3851\/IMP3173","volume":"23","author":"M Shilaih","year":"2018","unstructured":"Shilaih, M. et al. Antibacterial effects of antiretrovirals, potential implications for microbiome studies in HIV. Antivir. Ther. 23, 91\u201394 (2018).","journal-title":"Antivir. Ther."},{"key":"5177_CR11","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","volume":"555","author":"L Maier","year":"2018","unstructured":"Maier, L. et al. Extensive impact of non-antibiotic drugs on human gut bacteria. Nature 555, 623\u2013628 (2018).","journal-title":"Nature"},{"key":"5177_CR12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1021\/acsinfecdis.0c00536","volume":"7","author":"S Ray","year":"2021","unstructured":"Ray, S. et al. Altered gut microbiome under antiretroviral therapy: impact of efavirenz and zidovudine. ACS Infect. Dis. 7, 1104\u20131115 (2021).","journal-title":"ACS Infect. Dis."},{"key":"5177_CR13","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1021\/acs.jmedchem.6b00325","volume":"59","author":"M Serpi","year":"2016","unstructured":"Serpi, M., Ferrari, V. & Pertusati, F. Nucleoside derived antibiotics to fight microbial drug resistance: new utilities for an established class of drugs? J. Med. Chem. 59, 10343\u201310382 (2016).","journal-title":"J. Med. Chem."},{"key":"5177_CR14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/jac\/dkm240","volume":"60","author":"MPB Sandrini","year":"2007","unstructured":"Sandrini, M. P. B. et al. Nucleoside analogues are activated by bacterial deoxyribonucleoside kinases in a species-specific manner. J. Antimicrob. Chemother. 60, 510\u2013520 (2007).","journal-title":"J. Antimicrob. Chemother."},{"key":"5177_CR15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.3389\/fmicb.2019.00952","volume":"10","author":"JM Thomson","year":"2019","unstructured":"Thomson, J. M. & Lamont, I. L. Nucleoside analogues as antibacterial agents. Front. Microbiol. 10, 952 (2019).","journal-title":"Front. Microbiol."},{"key":"5177_CR16","unstructured":"WHO. Antimicrobial Resistance. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance (2020)."},{"key":"5177_CR17","unstructured":"CDC. Antibiotic Resistance Threats in the United States. www.cdc.gov\/DrugResistance\/Biggest-Threats.html (2019)."},{"key":"5177_CR18","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3201\/eid1106.050167","volume":"11","author":"S Harbarth","year":"2005","unstructured":"Harbarth, S. & Samore, M. H. Antimicrobial resistance determinants and future control. Emerg. Infect. Dis. 11, 794\u2013801 (2005).","journal-title":"Emerg. Infect. Dis."},{"key":"5177_CR19","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3201\/eid0702.010206","volume":"7","author":"RA Weinstein","year":"2001","unstructured":"Weinstein, R. A. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg. Infect. Dis. 7, 188\u2013192 (2001).","journal-title":"Emerg. Infect. Dis."},{"key":"5177_CR20","first-page":"e44","volume":"44","author":"JN Malag\u00f3n-Rojas","year":"2020","unstructured":"Malag\u00f3n-Rojas, J. N., Parra Barrera, E. L. & Lagos, L. From environment to clinic: the role of pesticides in antimicrobial resistance. Rev. Panam. Salud Publica 44, e44 (2020).","journal-title":"Rev. Panam. Salud Publica"},{"key":"5177_CR21","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1093\/molbev\/msab029","volume":"38","author":"H Liao","year":"2021","unstructured":"Liao, H. et al. Herbicide selection promotes antibiotic resistance in soil microbiomes. Mol. Biol. Evol. 38, 2337\u20132350 (2021).","journal-title":"Mol. Biol. Evol."},{"key":"5177_CR22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/mBio.00009-15","volume":"6","author":"B Kurenbach","year":"2015","unstructured":"Kurenbach, B. et al. Sublethal exposure to commercial formulations of the herbicides dicamba, 2,4-dichlorophenoxyacetic acid, and glyphosate cause changes in antibiotic susceptibility in Escherichia coli and Salmonella enterica serovar Typhimurium. MBio 6, 2 (2015).","journal-title":"MBio"},{"key":"5177_CR23","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1007\/s00203-022-02853-6","volume":"204","author":"SS Gurpinar","year":"2022","unstructured":"Gurpinar, S. S., Kart, D. & Eryilmaz, M. The effects of antidepressants fluoxetine, sertraline, and amitriptyline on the development of antibiotic resistance in Acinetobacter baumannii. Arch. Microbiol. 204, 230 (2022).","journal-title":"Arch. Microbiol."},{"key":"5177_CR24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41396-018-0275-x","volume":"13","author":"Y Wang","year":"2019","unstructured":"Wang, Y. et al. Antiepileptic drug carbamazepine promotes horizontal transfer of plasmid-borne multi-antibiotic resistance genes within and across bacterial genera. ISME J. 13, 509\u2013522 (2019).","journal-title":"ISME J."},{"key":"5177_CR25","first-page":"e00465","volume":"11","author":"EM Grimsey","year":"2022","unstructured":"Grimsey, E. M. et al. Chlorpromazine and amitriptyline are substrates and inhibitors of the AcrB multidrug efflux pump. MBio 11, e00465\u201320 (2022).","journal-title":"MBio"},{"key":"5177_CR26","doi-asserted-by":"crossref","first-page":"e2118566119","DOI":"10.1073\/pnas.2118566119","volume":"119","author":"J Zeng","year":"2022","unstructured":"Zeng, J. et al. A broadly applicable, stress-mediated bacterial death pathway regulated by the phosphotransferase system (PTS) and the cAMP-Crp cascade. Proc. Natl Acad. Sci. 119, e2118566119 (2022).","journal-title":"Proc. Natl Acad. Sci."},{"key":"5177_CR27","doi-asserted-by":"crossref","first-page":"807095","DOI":"10.3389\/fcimb.2022.807095","volume":"12","author":"Q Guo","year":"2022","unstructured":"Guo, Q. et al. Whole genome sequencing identifies novel mutations associated with bedaquiline resistance in mycobacterium tuberculosis. Front. Cell Infect. Microbiol. 12, 807095 (2022).","journal-title":"Front. Cell Infect. Microbiol."},{"key":"5177_CR28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jgar.2020.03.004","volume":"22","author":"N Hirani","year":"2020","unstructured":"Hirani, N. et al. Detection of a novel mutation in the rpoB gene in a multidrug resistant Mycobacterium tuberculosis isolate using whole genome next generation sequencing. J. Glob. Antimicrob. Resist. 22, 270\u2013274 (2020).","journal-title":"J. Glob. Antimicrob. Resist."},{"key":"5177_CR29","unstructured":"ATCC. Multidrug-Resistant and Antimicrobial Testing Reference Strains. https:\/\/www.atcc.org\/-\/media\/resources\/brochures\/multidrug-resistant-and-antimicrobial-testing-reference-materials.pdf (2019)."},{"key":"5177_CR30","doi-asserted-by":"crossref","first-page":"6559","DOI":"10.1073\/pnas.1001460107","volume":"107","author":"Y Takatsuka","year":"2010","unstructured":"Takatsuka, Y., Chen, C. & Nikaido, H. Mechanism of recognition of compounds of diverse structures by the multidrug efflux pump AcrB of Escherichia coli. Proc. Natl Acad. Sci. 107, 6559\u20136565 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"5177_CR31","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1073\/pnas.96.13.7190","volume":"96","author":"HI Zgurskaya","year":"1999","unstructured":"Zgurskaya, H. I. & Nikaido, H. Bypassing the periplasm: reconstitution of the AcrAB multidrug efflux pump of Escherichia coli. Proc. Natl Acad. Sci. USA 96, 7190\u20137195 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5177_CR32","doi-asserted-by":"crossref","first-page":"5853","DOI":"10.1128\/jb.178.20.5853-5859.1996","volume":"178","author":"H Nikaido","year":"1996","unstructured":"Nikaido, H. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178, 5853\u20135859 (1996).","journal-title":"J. Bacteriol."},{"key":"5177_CR33","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1086\/514920","volume":"27","author":"H Nikaido","year":"1998","unstructured":"Nikaido, H. Antibiotic resistance caused by gram-negative multidrug efflux pumps. Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am. 27, S32\u2013S41 (1998).","journal-title":"Clin. Infect. Dis. Publ. Infect. Dis. Soc. Am."},{"key":"5177_CR34","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3389\/fphar.2016.00535","volume":"7","author":"R El-Awady","year":"2017","unstructured":"El-Awady, R. et al. The role of eukaryotic and prokaryotic ABC transporter family in failure of chemotherapy. Front. Pharmacol. 7, 3389 (2017).","journal-title":"Front. Pharmacol."},{"key":"5177_CR35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1128\/MMBR.00020-06","volume":"70","author":"T Mascher","year":"2006","unstructured":"Mascher, T., Helmann, J. D. & Unden, G. Stimulus perception in bacterial signal-transducing histidine kinases. Microbiol. Mol. Biol. Rev. 70, 910\u2013938 (2006).","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"5177_CR36","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1128\/JCM.01368-17","volume":"56","author":"AE Lucas","year":"2018","unstructured":"Lucas, A. E. et al. Frequency and mechanisms of spontaneous fosfomycin nonsusceptibility observed upon disk diffusion testing of Escherichia coli. J. Clin. Microbiol. 56, 1128 (2018).","journal-title":"J. Clin. Microbiol."},{"key":"5177_CR37","first-page":"e00346","volume":"6","author":"B-B Sam","year":"2021","unstructured":"Sam, B.-B. et al. Machine learning prediction of resistance to subinhibitory antimicrobial concentrations from Escherichia coli genomes. mSystems 6, e00346\u201321 (2021).","journal-title":"mSystems"},{"key":"5177_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.envint.2018.06.004","volume":"118","author":"J Lu","year":"2018","unstructured":"Lu, J. et al. Non-antibiotic antimicrobial triclosan induces multiple antibiotic resistance through genetic mutation. Environ. Int. 118, 257\u2013265 (2018).","journal-title":"Environ. Int."},{"key":"5177_CR39","doi-asserted-by":"crossref","first-page":"e5801","DOI":"10.7717\/peerj.5801","volume":"6","author":"B Kurenbach","year":"2018","unstructured":"Kurenbach, B., Hill, A. M., Godsoe, W., van Hamelsveld, S. & Heinemann, J. A. Agrichemicals and antibiotics in combination increase antibiotic resistance evolution. PeerJ 6, e5801 (2018).","journal-title":"PeerJ"},{"key":"5177_CR40","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12199-015-0468-0","volume":"20","author":"S Fletcher","year":"2015","unstructured":"Fletcher, S. Understanding the contribution of environmental factors in the spread of antimicrobial resistance. Environ. Health Prev. Med. 20, 243\u2013252 (2015).","journal-title":"Environ. Health Prev. Med."},{"key":"5177_CR41","doi-asserted-by":"crossref","first-page":"18451","DOI":"10.1039\/D0RA01484B","volume":"10","author":"U Ndagi","year":"2020","unstructured":"Ndagi, U., Falaki, A. A., Abdullahi, M., Lawal, M. M. & Soliman, M. E. Antibiotic resistance: bioinformatics-based understanding as a functional strategy for drug design. RSC Adv. 10, 18451\u201318468 (2020).","journal-title":"RSC Adv."},{"key":"5177_CR42","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s00253-015-7202-0","volume":"100","author":"CM Manaia","year":"2016","unstructured":"Manaia, C. M., Macedo, G., Fatta-Kassinos, D. & Nunes, O. C. Antibiotic resistance in urban aquatic environments: can it be controlled? Appl. Microbiol. Biotechnol. 100, 1543\u20131557 (2016).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"5177_CR43","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4065\/mcp.2011.0358","volume":"86","author":"S Doron","year":"2011","unstructured":"Doron, S. & Davidson, L. E. Antimicrobial stewardship. Mayo Clin. Proc. 86, 1113\u20131123 (2011).","journal-title":"Mayo Clin. Proc."},{"key":"5177_CR44","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/jam.13468","volume":"123","author":"J Jang","year":"2017","unstructured":"Jang, J. et al. Environmental Escherichia coli: ecology and public health implications\u2014a review. J. Appl. Microbiol. 123, 570\u2013581 (2017).","journal-title":"J. Appl. Microbiol."},{"key":"5177_CR45","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/CMR.00073-09","volume":"23","author":"EJ Bottone","year":"2010","unstructured":"Bottone, E. J. Bacillus cereus, a volatile human pathogen. Clin. Microbiol. Rev. 23, 382\u2013398 (2010).","journal-title":"Clin. Microbiol. Rev."},{"key":"5177_CR46","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.3389\/fmicb.2020.599524","volume":"11","author":"A Bianco","year":"2021","unstructured":"Bianco, A. et al. Characterization of Bacillus cereus group isolates from human bacteremia by whole-genome sequencing. Front. Microbiol. 11, 3389 (2021).","journal-title":"Front. Microbiol."},{"key":"5177_CR47","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJM199010113231501","volume":"323","author":"MA Fischl","year":"1990","unstructured":"Fischl, M. A. et al. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N. Engl. J. Med. 323, 1009\u20131014 (1990).","journal-title":"N. Engl. J. Med."},{"key":"5177_CR48","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/jac\/dkr360","volume":"66","author":"J Poeta","year":"2011","unstructured":"Poeta, J. et al. Plasma concentrations of efavirenz are associated with body weight in HIV-positive individuals. J. Antimicrob. Chemother. 66, 2601\u20132604 (2011).","journal-title":"J. Antimicrob. Chemother."},{"key":"5177_CR49","doi-asserted-by":"crossref","first-page":"109752","DOI":"10.1016\/j.jenvman.2019.109752","volume":"254","author":"KO K\u2019oreje","year":"2020","unstructured":"K\u2019oreje, K. O., Okoth, M., Van Langenhove, H. & Demeestere, K. Occurrence and treatment of contaminants of emerging concern in the African aquatic environment: Literature review and a look ahead. J. Environ. Manag. 254, 109752 (2020).","journal-title":"J. Environ. Manag."},{"key":"5177_CR50","doi-asserted-by":"crossref","first-page":"134322","DOI":"10.1016\/j.scitotenv.2019.134322","volume":"699","author":"C Nannou","year":"2020","unstructured":"Nannou, C. et al. Antiviral drugs in aquatic environment and wastewater treatment plants: a review on occurrence, fate, removal and ecotoxicity. Sci. Total Environ. 699, 134322 (2020).","journal-title":"Sci. Total Environ."},{"key":"5177_CR51","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1128\/AAC.39.3.645","volume":"39","author":"N Masuda","year":"1995","unstructured":"Masuda, N., Sakagawa, E. & Ohya, S. Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 39, 645\u2013649 (1995).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5177_CR52","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/eva.12196","volume":"8","author":"AH Melnyk","year":"2015","unstructured":"Melnyk, A. H., Wong, A. & Kassen, R. The fitness costs of antibiotic resistance mutations. Evol. Appl. 8, 273\u2013283 (2015).","journal-title":"Evol. Appl."},{"key":"5177_CR53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3109\/03009734.2014.904457","volume":"119","author":"L Sandegren","year":"2014","unstructured":"Sandegren, L. Selection of antibiotic resistance at very low antibiotic concentrations. Ups. J. Med. Sci. 119, 103\u2013107 (2014).","journal-title":"Ups. J. Med. Sci."},{"key":"5177_CR54","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.mib.2003.09.001","volume":"6","author":"DI Andersson","year":"2003","unstructured":"Andersson, D. I. Persistence of antibiotic resistant bacteria. Curr. Opin. Microbiol. 6, 452\u2013456 (2003).","journal-title":"Curr. Opin. Microbiol."},{"key":"5177_CR55","doi-asserted-by":"crossref","first-page":"eadd0924","DOI":"10.1126\/sciadv.add0924","volume":"8","author":"G Diaz-Tang","year":"2023","unstructured":"Diaz-Tang, G. et al. Growth productivity as a determinant of the inoculum effect for bactericidal antibiotics. Sci. Adv. 8, eadd0924 (2023).","journal-title":"Sci. Adv."},{"key":"5177_CR56","first-page":"354","volume":"LI","author":"WH Prusoff","year":"1969","unstructured":"Prusoff, W. H. & Chen, M. S. Thymidine kinase from Escherichia coli. J. Biol. Chem. LI, 354\u2013360 (1969).","journal-title":"J. Biol. Chem."},{"key":"5177_CR57","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1134\/S0026893321040105","volume":"55","author":"AA Zenchenko","year":"2021","unstructured":"Zenchenko, A. A., Drenichev, M. S., Il\u2019icheva, I. A. & Mikhailov, S. N. Antiviral and antimicrobial nucleoside derivatives: structural features and mechanisms of action. Mol. Biol. 55, 786\u2013812 (2021).","journal-title":"Mol. Biol."},{"key":"5177_CR58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3390\/genes12081125","volume":"12","author":"L Antoine","year":"2021","unstructured":"Antoine, L. et al. RNA modifications in pathogenic bacteria: impact on host adaptation and virulence. Genes 12, 8 (2021).","journal-title":"Genes"},{"key":"5177_CR59","doi-asserted-by":"crossref","first-page":"uqac019","DOI":"10.1093\/femsml\/uqac019","volume":"3","author":"A Babosan","year":"2022","unstructured":"Babosan, A. et al. Non-essential tRNA and rRNA modifications impact the bacterial response to sub-MIC antibiotic stress. MicroLife 3, uqac019 (2022).","journal-title":"MicroLife"},{"key":"5177_CR60","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12224-3","volume":"10","author":"EJ Hasenoehrl","year":"2019","unstructured":"Hasenoehrl, E. J. et al. Derailing the aspartate pathway of Mycobacterium tuberculosis to eradicate persistent infection. Nat. Commun. 10, 4215 (2019).","journal-title":"Nat. Commun."},{"key":"5177_CR61","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/ml400328a","volume":"4","author":"C Shi","year":"2013","unstructured":"Shi, C. et al. Bisubstrate inhibitors of biotin protein ligase in Mycobacterium tuberculosis resistant to cyclonucleoside formation. ACS Med. Chem. Lett. 4, 1213\u20131217 (2013).","journal-title":"ACS Med. Chem. Lett."},{"key":"5177_CR62","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/antibiotics5030026","volume":"5","author":"J Feng","year":"2016","unstructured":"Feng, J., Paparella, A. S., Booker, G. W., Polyak, S. W. & Abell, A. D. Biotin protein ligase is a target for new antibacterials. Antibiot 5, 26 (2016).","journal-title":"Antibiot"},{"key":"5177_CR63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1089\/mdr.2009.0891","volume":"15","author":"AG Tait-Kamradt","year":"2009","unstructured":"Tait-Kamradt, A. G., Cronan, M. & Dougherty, T. J. Comparative genome analysis of high-level penicillin resistance in Streptococcus pneumoniae. Microb. Drug Resist. 15, 69\u201375 (2009).","journal-title":"Microb. Drug Resist."},{"key":"5177_CR64","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1128\/jb.179.10.3342-3349.1997","volume":"179","author":"T Grebe","year":"1997","unstructured":"Grebe, T., Paik, J. & Hakenbeck, R. A novel resistance mechanism against beta-lactams in Streptococcus pneumoniae involves CpoA, a putative glycosyltransferase. J. Bacteriol. 179, 3342\u20133349 (1997).","journal-title":"J. Bacteriol."},{"key":"5177_CR65","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1471-2180-9-121","volume":"9","author":"R Dias","year":"2009","unstructured":"Dias, R., F\u00e9lix, D., Cani\u00e7a, M. & Trombe, M.-C. The highly conserved serine threonine kinase StkP of Streptococcus pneumoniae contributes to penicillin susceptibility independently from genes encoding penicillin-binding proteins. BMC Microbiol 9, 121 (2009).","journal-title":"BMC Microbiol"},{"key":"5177_CR66","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/j.1365-2958.2010.07271.x","volume":"77","author":"M Moscoso","year":"2010","unstructured":"Moscoso, M., Domenech, M. & Garc\u00eda, E. Vancomycin tolerance in clinical and laboratory Streptococcus pneumoniae isolates depends on reduced enzyme activity of the major LytA autolysin or cooperation between CiaH histidine kinase and capsular polysaccharide. Mol. Microbiol 77, 1052\u20131064 (2010).","journal-title":"Mol. Microbiol"},{"key":"5177_CR67","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1099\/00222615-33-4-235","volume":"33","author":"CS Lewin","year":"1990","unstructured":"Lewin, C. S., Allen, R. A. & Amyes, S. G. Mechanisms of zidovudine resistance in bacteria. J. Med. Microbiol. 33, 235\u2013238 (1990).","journal-title":"J. Med. Microbiol."},{"key":"5177_CR68","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1007\/s10096-011-1220-3","volume":"30","author":"A Doleans-Jordheim","year":"2011","unstructured":"Doleans-Jordheim, A. et al. Zidovudine (AZT) has a bactericidal effect on enterobacteria and induces genetic modifications in resistant strains. Eur. J. Clin. Microbiol. Infect. Dis. 30, 1249\u20131256 (2011).","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"5177_CR69","doi-asserted-by":"crossref","first-page":"eabg6165","DOI":"10.1126\/sciadv.abg6165","volume":"7","author":"Y Ariav","year":"2022","unstructured":"Ariav, Y., Ch\u2019ng, J. H., Christofk, H. R., Ron-Harel, N. & Erez, A. Targeting nucleotide metabolism as the nexus of viral infections, cancer, and the immune response. Sci. Adv. 7, eabg6165 (2022).","journal-title":"Sci. Adv."},{"key":"5177_CR70","doi-asserted-by":"crossref","first-page":"e00165","DOI":"10.1128\/AAC.00165-17","volume":"61","author":"MC Bagatin","year":"2017","unstructured":"Bagatin, M. C. et al. Targeting the homoserine dehydrogenase of paracoccidioides species for treatment of systemic fungal infections. Antimicrob. Agents Chemother. 61, e00165\u201317 (2017).","journal-title":"Antimicrob. Agents Chemother."},{"key":"5177_CR71","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-12-583","volume":"12","author":"DP Sangurdekar","year":"2011","unstructured":"Sangurdekar, D. P., Zhang, Z. & Khodursky, A. B. The association of DNA damage response and nucleotide level modulation with the antibacterial mechanism of the anti-folate drug Trimethoprim. BMC Genom. 12, 583 (2011).","journal-title":"BMC Genom."},{"key":"5177_CR72","first-page":"e03355","volume":"11","author":"MMC Buckner","year":"2020","unstructured":"Buckner, M. M. C. et al. HIV drugs inhibit transfer of plasmids carrying extended-spectrum \u03b2-Lactamase and carbapenemase genes. MBio 11, e03355\u201319 (2020).","journal-title":"MBio"},{"key":"5177_CR73","doi-asserted-by":"crossref","first-page":"22484","DOI":"10.1073\/pnas.2004977117","volume":"117","author":"N O\u2019Boyle","year":"2020","unstructured":"O\u2019Boyle, N., Connolly, J. P. R., Tucker, N. P. & Roe, A. J. Genomic plasticity of pathogenic Escherichia coli mediates d-serine tolerance via multiple adaptive mechanisms. Proc. Natl Acad. Sci. USA 117, 22484\u201322493 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"5177_CR74","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijmm.2010.04.010","volume":"300","author":"U Dobrindt","year":"2010","unstructured":"Dobrindt, U., Zdziarski, J., Salvador, E. & Hacker, J. Bacterial genome plasticity and its impact on adaptation during persistent infection. Int. J. Med. Microbiol. 300, 363\u2013366 (2010).","journal-title":"Int. J. Med. Microbiol."},{"key":"5177_CR75","first-page":"e03860","volume":"11","author":"C-S Anna","year":"2022","unstructured":"Anna, C.-S. et al. Genetic adaptation and acquisition of macrolide resistance in Haemophilus spp. during persistent respiratory tract colonization in Chronic Obstructive Pulmonary Disease (COPD) patients receiving long-term Azithromycin treatment. Microbiol. Spectr. 11, e03860\u201322 (2022).","journal-title":"Microbiol. Spectr."},{"key":"5177_CR76","first-page":"e0010921","volume":"203","author":"H Cho","year":"2021","unstructured":"Cho, H. & Misra, R. Mutational activation of antibiotic-resistant mechanisms in the absence of major drug efflux systems of Escherichia coli. J. Bacteriol. 203, e0010921 (2021).","journal-title":"J. Bacteriol."},{"key":"5177_CR77","doi-asserted-by":"crossref","first-page":"100045","DOI":"10.1016\/j.wroa.2020.100045","volume":"7","author":"E Buelow","year":"2020","unstructured":"Buelow, E. et al. Hospital discharges in urban sanitation systems: long-term monitoring of wastewater resistome and microbiota in relationship to their eco-exposome. Water Res. X. 7, 100045 (2020).","journal-title":"Water Res. X."},{"key":"5177_CR78","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.watres.2019.06.073","volume":"162","author":"J Bengtsson-Palme","year":"2019","unstructured":"Bengtsson-Palme, J. et al. Industrial wastewater treatment plant enriches antibiotic resistance genes and alters the structure of microbial communities. Water Res 162, 437\u2013445 (2019).","journal-title":"Water Res"},{"key":"5177_CR79","doi-asserted-by":"crossref","first-page":"106436","DOI":"10.1016\/j.envint.2021.106436","volume":"150","author":"N Kraupner","year":"2021","unstructured":"Kraupner, N. et al. Evidence for selection of multi-resistant E. coli by hospital effluent. Environ. Int. 150, 106436 (2021).","journal-title":"Environ. Int."},{"key":"5177_CR80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/mbo3.319","volume":"5","author":"MA Adefisoye","year":"2016","unstructured":"Adefisoye, M. A. & Okoh, A. I. Identification and antimicrobial resistance prevalence of pathogenic Escherichia coli strains from treated wastewater effluents in Eastern Cape, South Africa. MicrobiologyOpen 5, 143\u2013151 (2016).","journal-title":"MicrobiologyOpen"},{"key":"5177_CR81","doi-asserted-by":"crossref","first-page":"e62712","DOI":"10.1371\/journal.pone.0062712","volume":"8","author":"GA Khan","year":"2013","unstructured":"Khan, G. A., Berglund, B., Khan, K. M., Lindgren, P.-E. & Fick, J. Occurrence and abundance of antibiotics and resistance genes in rivers, canal and near drug formulation facilities\u2014a study in Pakistan. PLoS One 8, e62712 (2013).","journal-title":"PLoS One"},{"key":"5177_CR82","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.watres.2018.08.017","volume":"145","author":"S Ncube","year":"2018","unstructured":"Ncube, S., Madikizela, L. M., Chimuka, L. & Nindi, M. M. Environmental fate and ecotoxicological effects of antiretrovirals: a current global status and future perspectives. Water Res 145, 231\u2013247 (2018).","journal-title":"Water Res"},{"key":"5177_CR83","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.chemosphere.2018.12.205","volume":"220","author":"TT Mosekiemang","year":"2019","unstructured":"Mosekiemang, T. T., Stander, M. A. & de Villiers, A. Simultaneous quantification of commonly prescribed antiretroviral drugs and their selected metabolites in aqueous environmental samples by direct injection and solid phase extraction liquid chromatography\u2014tandem mass spectrometry. Chemosphere 220, 983\u2013992 (2019).","journal-title":"Chemosphere"},{"key":"5177_CR84","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1021\/es903216p","volume":"44","author":"C Prasse","year":"2010","unstructured":"Prasse, C., Schl\u00fcsener, M. P., Schulz, R. & Ternes, T. A. Antiviral drugs in wastewater and surface waters: a new pharmaceutical class of environmental relevance? Environ. Sci. Technol. 44, 1728\u20131735 (2010).","journal-title":"Environ. Sci. Technol."},{"key":"5177_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11270-012-1410-3","volume":"224","author":"S Jain","year":"2013","unstructured":"Jain, S., Kumar, P., Vyas, R. K., Pandit, P. & Dalai, A. Occurrence and removal of antiviral drugs in environment: a review. Water Air Soil Pollut. 224, 1\u201319 (2013).","journal-title":"Water Air Soil Pollut."},{"key":"5177_CR86","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.chemosphere.2016.01.095","volume":"149","author":"KO K\u2019oreje","year":"2016","unstructured":"K\u2019oreje, K. O. et al. Occurrence patterns of pharmaceutical residues in wastewater, surface water and groundwater of Nairobi and Kisumu City, Kenya. Chemosphere 149, 238\u2013244 (2016).","journal-title":"Chemosphere"},{"key":"5177_CR87","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/j.scitotenv.2010.07.074","volume":"408","author":"AJ Al-Rajab","year":"2010","unstructured":"Al-Rajab, A. J., Sabourin, L., Chapman, R., Lapen, D. R. & Topp, E. Fate of the antiretroviral drug tenofovir in agricultural soil. Sci. Total Environ. 408, 5559\u20135564 (2010).","journal-title":"Sci. Total Environ."},{"key":"5177_CR88","doi-asserted-by":"crossref","first-page":"8585","DOI":"10.1007\/s00216-015-9017-3","volume":"407","author":"Y Aminot","year":"2015","unstructured":"Aminot, Y. et al. Development and application of a multi-residue method for the determination of 53 pharmaceuticals in water, sediment, and suspended solids using liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 407, 8585\u20138604 (2015).","journal-title":"Anal. Bioanal. Chem."},{"key":"5177_CR89","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev.mi.03.100149.002103","volume":"3","author":"J Monod","year":"1949","unstructured":"Monod, J. The growth of bacterial cultures. Annu. Rev. Microbiol. 3, 371\u2013394 (1949).","journal-title":"Annu. Rev. Microbiol."},{"key":"5177_CR90","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s13201-020-1171-x","volume":"10","author":"HAO Alisawi","year":"2020","unstructured":"Alisawi, H. A. O. Performance of wastewater treatment during variable temperature. Appl. Water Sci. 10, 89 (2020).","journal-title":"Appl. Water Sci."},{"key":"5177_CR91","first-page":"10,773","volume":"42","author":"CM O\u2019Reilly","year":"2015","unstructured":"O\u2019Reilly, C. M. et al. Rapid and highly variable warming of lake surface waters around the globe. Geophys. Res. Lett. 42, 10,773\u201310,781 (2015).","journal-title":"Geophys. Res. Lett."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05177-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05177-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05177-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T07:30:11Z","timestamp":1700206211000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-023-05177-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,12]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["5177"],"URL":"https:\/\/doi.org\/10.1038\/s42003-023-05177-3","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,12]]},"assertion":[{"value":"5 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"837"}}